Skip to main content

Change location

You are currently on the Global (English) website

My country is not on the list

Global

  • Bracco.com (English)

Asia

  • China (中文)
  • Japan (日本語)
  • South Korea (한국어)

Americas

  • Brazil (Português)
  • Canada (English)
  • Mexico (Español)
  • Canada (Français)
  • USA (English)

Europe

  • Austria (English)
  • Belgium (English)
  • Czech Republic (English)
  • Denmark (English)
  • Finland (English)
  • France (Français)
  • Germany (Deutsch)
  • Iceland (English)
  • Italy (Italiano)
  • Luxembourg (English)
  • Norway (English)
  • Poland (English)
  • Slovakia (English)
  • Sweden (English)
  • Switzerland (English)
  • The Netherlands (English)
  • UK (English)
  • Global (English)
  • Careers
  • Media and News
  • Get in touch
    • Global (English)
    • We are Bracco
    • Our businesses
    • Purpose and values
    • Our history
    • Our Foundation
    • Responsibility and Ethical conduct
    • Product overview
    • X-ray/CT
    • MRI
    • CEUS
    • Molecular Imaging
    • Cardiovascular
    • Digital Health
    • Oncology
    • Cardiology
    • Innovation
    • Digital future
    • R&D
    • The Bracco sites
    • Scientific heritage and patents
      • Cell Therapy
      • Research Products
        • BubbleGen CD3+ Cell Selection Kit
        • BubbleGen Cell Separators
      • Resources
    • Education
    • Next-Gen Projects
    • Bracco Global Academy
    • Our Partnerships
    • Events
    • Key International conferences
    • Global Educational events
    • Sustainability Overview
    • Decarbonization and Environment
    • Innovation and Education
    • Empowering People
    • Trust and Governance
  • Our Stories
232 results found
Article
Talking Images podcast: The sustainable way – voices of action Talking Images podcast: The sustainable way – voices of action. What do environmental sustainability and sustainable future mean?
sustainability podcast
Article
The Bracco Fellowships are back 95 grants to celebrate Bracco’s 95th Anniversary
fellowship
Article
BIPSO further strengthens environmental protection BIPSO sets the course for sterile contrast media production according to the latest environmental standards.
BIPSO production site
Article
FDA approves Gadopiclenol injection for the U.S. market Bracco Announces FDA Approval of Gadopiclenol Injection, a New Macrocyclic High-Relaxivity Gadolinium-Based Contrast Agent which will be commercialized as VUEWAY™ (gadopiclenol) injection and VUEWAY™ (gadopiclenol) Pharmacy Bulk Package by Bracco.
Vueway Gadopiclenol
Article
Gadopiclenol: another milestone achieved Bracco Imaging and Guerbet have a worldwide collaboration on Gadopiclenol, an investigational macrocyclic gadolinium-based contrast agent (GBCA).
Vueway Gadopiclenol: another milestone achieved
Page
Distributors list Distributors list
Bracco logo
Product
Product template
No image available
Page
Data protection Data Protection  
Bracco logo
Page
Cookie Policy Cookie Policy
Bracco logo
Page
Search Search page
Bracco logo
  • Load More

The Bracco Group is an international group of highly specialized companies.
We are an active part of the healthcare sector, and a global leader in diagnostic imaging.

  • We are Bracco
  • Our Portfolio
  • Innovation
  • Education
  • Events
  • Our Stories
  • Pharmacovigilance
  • Data Protection

Connect with us

Via Egidio Folli 50
20134 Milan, Italy
Phone + 39 02 2177.1

  • Terms of Use
  • Privacy Policy
  • Cookie Policy
  • Imprint
  • for Bracco VPN users

Bracco Copyright © 2026 | Registered office: Via E. Folli, 50, 20134 Milano, Italy | Share Capital € 104.000.000 f.p. | VAT Milan Comp. Reg. n. 00825120157 | Milan REA n. 348182